INVESTMENTS

9 Months Ended

Sep. 30, 2022

Investments, Debt and Equity Securities [Abstract]

As of September 30, 2022, investments were comprised of the following:


	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Commercial paper	$	4,999	$	—	$	(1)	$	4,998
Corporate bonds	47,581		—		(1,143)		46,438
U.S. Government agencies	40,129		—		(1,344)		38,785
Total	$	92,709	$	—	$	(2,488)	$	90,221

As of December 31, 2021, investments were comprised of the following:


	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value

Corporate bonds	$	104,261	$	47	$	(242)	$	104,066
U.S. Government agencies	40,140		—		(219)		39,921
Total	$	144,401	$	47	$	(461)	$	143,987

As of September 30, 2022, all marketable securities held by the Company had remaining contractual maturities of one year or less, except for U.S. government agencies, corporate bonds and commercial paper with a fair value of $44,587 that had maturities of one to three years.

As of December 31, 2021, all marketable securities held by the Company had remaining contractual maturities of one year or less, except for U.S. government agencies and corporate bonds with a fair value of $86,187 that had maturities of one to three years.

As of September 30, 2022, the marketable securities in a loss position had a maturity of less than one year, except for U.S. government agencies, corporate bonds and commercial paper with a fair value of $44,587, that had maturities of one to three years. As of December 31, 2021, the marketable securities in a loss position had a maturity of less than one year, except for U.S. government agencies and corporate bonds, with a fair value of $86,187, that had maturities of one to three years.

As of September 30, 2022, the Company reviewed its investment portfolio to assess whether the unrealized losses on its available-for-sale investments were temporary. In determining whether the decline in fair value of these securities was temporary, the Company evaluated whether it intended to sell the security and whether it was more likely than not that the Company would be required to sell the security before recovering its amortized cost basis. There have been no impairments of the Company’s assets measured and carried at fair value during the nine months ended September 30, 2022 and the year ended December 31, 2021.